A Quon

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. pmc Initial investigation of ¹⁸F-NaF PET/CT for identification of vertebral sites amenable to surgical revision after spinal fusion surgery
    Andrew Quon
    Department of Radiology Division of Nuclear Medicine, Stanford University Medical Center, Palo Alto, USA
    Eur J Nucl Med Mol Imaging 39:1737-44. 2012
  2. pmc Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's disease
    Diane Tseng
    Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Dr, Stanford, CA 94305, USA
    Radiat Oncol 7:5. 2012
  3. ncbi request reprint Initial evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer
    A Quon
    Department of Radiology and Molecular Imaging Program at Stanford, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, USA
    Eur J Nucl Med Mol Imaging 35:527-31. 2008
  4. ncbi request reprint FDG-PET and beyond: molecular breast cancer imaging
    Andrew Quon
    Department of Radiology, Division of Nuclear Medicine, Molecular Imaging Program, Stanford University Medical Center, 300 Pasteur Drive H 0101, Stanford, CA 94305 5281, USA
    J Clin Oncol 23:1664-73. 2005
  5. ncbi request reprint Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma
    Andrew Quon
    Division of Nuclear Medicine, Department of Radiology, Stanford University Medical Center, Stanford, California 94305, USA
    J Nucl Med 48:58S-67S. 2007
  6. ncbi request reprint "Flying through" and "flying around" a PET/CT scan: Pilot study and development of 3D integrated 18F-FDG PET/CT for virtual bronchoscopy and colonoscopy
    Andrew Quon
    Molecular Imaging Program at Stanford, Department of Radiology and Bioengineering, Stanford University, Stanford, California 94305 5281, USA
    J Nucl Med 47:1081-7. 2006
  7. ncbi request reprint 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma
    A Iagaru
    Division of Nuclear Medicine, Department of Radiology, Stanford Hospital and Clinics, Stanford, CA, USA
    Mol Imaging Biol 9:50-7. 2007
  8. doi request reprint Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study
    Andrei Iagaru
    Division of Nuclear Medicine, Stanford University Medical Center, Stanford, California, USA
    J Nucl Med 50:501-5. 2009
  9. ncbi request reprint Diagnosis of aseptic deep venous thrombosis of the upper extremity in a cancer patient using fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT)
    B Do
    Stanford University Medical Center, Nuclear Medicine Division, Department of Radiology and Molecular Imaging Program at Stanford, USA
    Ann Nucl Med 20:151-5. 2006
  10. ncbi request reprint Metabolic tumor burden predicts for disease progression and death in lung cancer
    Percy Lee
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 69:328-33. 2007

Collaborators

Detail Information

Publications39

  1. pmc Initial investigation of ¹⁸F-NaF PET/CT for identification of vertebral sites amenable to surgical revision after spinal fusion surgery
    Andrew Quon
    Department of Radiology Division of Nuclear Medicine, Stanford University Medical Center, Palo Alto, USA
    Eur J Nucl Med Mol Imaging 39:1737-44. 2012
    ....
  2. pmc Interim-treatment quantitative PET parameters predict progression and death among patients with Hodgkin's disease
    Diane Tseng
    Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wilbur Dr, Stanford, CA 94305, USA
    Radiat Oncol 7:5. 2012
    ..We hypothesized that quantitative PET parameters may have predictive value beyond that of traditional clinical factors such as the International Prognostic Score (IPS) among Hodgkin's disease (HD) patients...
  3. ncbi request reprint Initial evaluation of 18F-fluorothymidine (FLT) PET/CT scanning for primary pancreatic cancer
    A Quon
    Department of Radiology and Molecular Imaging Program at Stanford, Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA 94305, USA
    Eur J Nucl Med Mol Imaging 35:527-31. 2008
    ..The aim of this study was to evaluate the potential of (18)F-fluorothymidine (FLT) PET/CT for imaging pancreatic adenocarcinoma...
  4. ncbi request reprint FDG-PET and beyond: molecular breast cancer imaging
    Andrew Quon
    Department of Radiology, Division of Nuclear Medicine, Molecular Imaging Program, Stanford University Medical Center, 300 Pasteur Drive H 0101, Stanford, CA 94305 5281, USA
    J Clin Oncol 23:1664-73. 2005
  5. ncbi request reprint Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma
    Andrew Quon
    Division of Nuclear Medicine, Department of Radiology, Stanford University Medical Center, Stanford, California 94305, USA
    J Nucl Med 48:58S-67S. 2007
    ....
  6. ncbi request reprint "Flying through" and "flying around" a PET/CT scan: Pilot study and development of 3D integrated 18F-FDG PET/CT for virtual bronchoscopy and colonoscopy
    Andrew Quon
    Molecular Imaging Program at Stanford, Department of Radiology and Bioengineering, Stanford University, Stanford, California 94305 5281, USA
    J Nucl Med 47:1081-7. 2006
    ..quot;..
  7. ncbi request reprint 2-Deoxy-2-[F-18]fluoro-D-glucose positron emission tomography/computed tomography in the management of melanoma
    A Iagaru
    Division of Nuclear Medicine, Department of Radiology, Stanford Hospital and Clinics, Stanford, CA, USA
    Mol Imaging Biol 9:50-7. 2007
    ..Therefore, we were prompted to review our experience with FDG-PET/CT in the management of melanoma...
  8. doi request reprint Novel strategy for a cocktail 18F-fluoride and 18F-FDG PET/CT scan for evaluation of malignancy: results of the pilot-phase study
    Andrei Iagaru
    Division of Nuclear Medicine, Stanford University Medical Center, Stanford, California, USA
    J Nucl Med 50:501-5. 2009
    ..Sodium (18)F was previously used for bone imaging and can be used as a PET/CT skeletal tracer. The combined administration of (18)F and (18)F-FDG in a single PET/CT study for cancer detection has not been reported to date...
  9. ncbi request reprint Diagnosis of aseptic deep venous thrombosis of the upper extremity in a cancer patient using fluorine-18 fluorodeoxyglucose positron emission tomography/computerized tomography (FDG PET/CT)
    B Do
    Stanford University Medical Center, Nuclear Medicine Division, Department of Radiology and Molecular Imaging Program at Stanford, USA
    Ann Nucl Med 20:151-5. 2006
    ..After revision of the patient's clinical history, tests and physical exam, the abnormal FDG uptake was found to correspond to an extensive aseptic deep venous thrombosis of the upper extremity...
  10. ncbi request reprint Metabolic tumor burden predicts for disease progression and death in lung cancer
    Percy Lee
    Department of Radiation Oncology, Stanford University, Stanford, CA 94305 5847, USA
    Int J Radiat Oncol Biol Phys 69:328-33. 2007
    ..However, stage may be simply a surrogate for underlying tumor burden. Our purpose was to assess the prognostic value of tumor burden measured by 18F-fluorodeoxyglucose-positron emission tomography (FDG-PET) imaging...
  11. ncbi request reprint Detection of bone metastases: assessment of integrated FDG PET/CT imaging
    Al V Taira
    Department of Radiology Division of Nuclear Medicine, Molecular Imaging Program at Stanford, Stanford University Medical Center, CA 94305, USA
    Radiology 243:204-11. 2007
    ....
  12. doi request reprint Simulations of virtual PET/CT 3-D bronchoscopy imaging using a physical porcine lung-heart phantom
    David Yerushalmi
    Department of Bioengineering, Stanford University, The James H Clark Center, 318 Campus Drive, E150, Stanford, CA 94305, USA
    Mol Imaging Biol 11:275-82. 2009
    ....
  13. ncbi request reprint FDG PET/CT detection of a gossypiboma in the neck
    Ryan D Niederkohr
    Division of Nuclear Medicine, Stanford University Hospital and Clinics, Stanford, California, USA
    Clin Nucl Med 32:893-5. 2007
  14. ncbi request reprint (18)F-FDG-PET/CT evaluation of response to treatment in lymphoma: when is the optimal time for the first re-evaluation scan?
    Andrei Iagaru
    Division of Nuclear Medicine, Stanford University Medical Center, 300 Pasteur Dr, Room H 0101, Stanford, CA 94305 5427, USA
    Hell J Nucl Med 11:153-6. 2008
    ..80 in group B. Results of PET/CT after 2 cycles of chemotherapy did not statistically differ from the results of PET/CT after 4 cycles of chemotherapy. These results need to be confirmed in larger, prospective, randomized trials...
  15. doi request reprint Positron emission tomography/computed tomography: the current technology and applications
    Erik Mittra
    Division of Nuclear Medicine, Stanford Hospital and Clinics, 300 Pasteur Drive, Room H0101, Stanford, CA 94305, USA
    Radiol Clin North Am 47:147-60. 2009
    ..Additionally, novel radiopharmeuticals are under development, many of which are target cellular processes that are more specific than glucose metabolism...
  16. pmc Interim positron emission tomography scans in diffuse large B-cell lymphoma: an independent expert nuclear medicine evaluation of the Eastern Cooperative Oncology Group E3404 study
    Sandra J Horning
    Department of Medicine, Stanford University, CA, USA
    Blood 115:775-7; quiz 918. 2010
    ..This trial was registered at www.clinicaltrials.gov as #NCT00274924 [corrected]...
  17. ncbi request reprint Impact of positive positron emission tomography on prediction of freedom from progression after Stanford V chemotherapy in Hodgkin's disease
    Ranjana Advani
    Stanford University Comprehensive Cancer Center, Stanford, CA 94305, USA
    J Clin Oncol 25:3902-7. 2007
    ..To correlate [(18)F]fluorodeoxyglucose positron emission tomography ([(18)F]FDG-PET) status after chemotherapy, but before radiation, with outcome in patients treated with the Stanford V regimen...
  18. ncbi request reprint Advances in metabolic imaging for surgical oncology
    Andrei Iagaru
    Division of Nuclear Medicine, Stanford University Medical Center, 300 Pasteur Drive, Room H 0101, Stanford, CA 94305, USA
    Surg Oncol Clin N Am 16:273-92. 2007
    ..Finally, advances in molecular imaging that may herald the next generation of PET radiotracers beyond (18)F FDG are reviewed...
  19. pmc 18F-FDG PET/CT evaluation of patients with ovarian carcinoma
    Andrei H Iagaru
    Department of Radiolog, Stanford Hospital and Clinics, Stanford, CA, USA
    Nucl Med Commun 29:1046-51. 2008
    ..Therefore, we were prompted to review our experience with PET/CT in the management of patients with ovarian carcinoma...
  20. ncbi request reprint No apparent alteration of F-18 FDG biodistribution when injected shortly after insulin glargine
    Ryan D Niederkohr
    Division of Nuclear Medicine, Stanford University Medical Center, Stanford, CA 94305 5281, USA
    Clin Nucl Med 32:302-3. 2007
  21. ncbi request reprint RT_Image: an open-source tool for investigating PET in radiation oncology
    Edward E Graves
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA 94305, USA
    Technol Cancer Res Treat 6:111-21. 2007
    ..The development of tools such as this is critical in order to realize the potential of molecular imaging-guided radiation therapy...
  22. ncbi request reprint Staging accuracy in mycosis fungoides and sezary syndrome using integrated positron emission tomography and computed tomography
    Eunice Y Tsai
    Department of Dermatology, Stanford University School of Medicine, Stanford, Calif, USA
    Arch Dermatol 142:577-84. 2006
    ..To evaluate the usefulness of integrated positron emission tomography and computed tomography (PET/CT) in staging mycosis fungoides (MF) and Sézary syndrome and to correlate PET/CT data with histopathologic diagnosis of lymph nodes (LNs)...
  23. ncbi request reprint Sonography of the abnormal parathyroid gland
    Aya Kamaya
    Abdominal Imaging Section, Department of Radiology, Stanford University, Stanford, CA 94305 5105, USA
    Ultrasound Q 22:253-62. 2006
    ..Proper neck extension, unilateral graded compression techniques, and patient swallowing will improve visualization of adenomas...
  24. ncbi request reprint F-18 fluorodeoxyglucose PET/CT as an imaging tool for staging and restaging cutaneous angiosarcoma of the scalp
    Minal S Vasanawala
    Department of Radiology, Division of Nuclear Medicine, Molecular Imaging Program at Stanford, MIPS, Stanford University Hospital and Clinics, California 94305 5427, USA
    Clin Nucl Med 31:534-7. 2006
    ....
  25. ncbi request reprint F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas
    Andrei Iagaru
    Division of Nuclear Medicine, Department of Radiology, Stanford Hospital and Clinics, Stanford, California, USA
    Clin Nucl Med 31:754-60. 2006
    ..Therefore, we were prompted to review our experience with F-18 FDG PET/CT in OSTS...
  26. ncbi request reprint Merkel cell carcinoma: Is there a role for 2-deoxy-2-[f-18]fluoro-D-glucose-positron emission tomography/computed tomography?
    A Iagaru
    Division of Nuclear Medicine, Department of Radiology, Stanford University Medical Center, 300 Pasteur Drive, H 0101, Stanford, CA 94305, USA
    Mol Imaging Biol 8:212-7. 2006
    ..We were therefore prompted to review our experience with FDG-PET/CT in the management of patients with Merkel cell carcinoma...
  27. ncbi request reprint Clinical value of including the head and lower extremities in 18F-FDG PET/CT imaging for patients with malignant melanoma
    Ryan D Niederkohr
    Division of Nuclear Medicine, Stanford University Medical Center, California 94305, USA
    Nucl Med Commun 28:688-95. 2007
    ..To assess the added benefit of scanning lower extremities and skull in addition to 'skull base to upper thigh' images in PET/CT evaluation of metastatic melanoma...
  28. ncbi request reprint 123I MIBG mapping with intraoperative gamma probe for recurrent neuroblastoma
    Andrei Iagaru
    Department of Radiology, Division of Nuclear Medicine, Stanford University Medical Center, Stanford, CA 94305 5427, USA
    Mol Imaging Biol 10:19-23. 2008
    ..Intraoperative gamma probe mapping of the liver identified areas with signal above the background, but these were prove to be hemosiderin deposits on histo-pathology examination...
  29. doi request reprint Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas
    Daniel T Chang
    Department of Radiation Oncology, Stanford University Medical Center, Stanford, California 94305 5847, USA
    Cancer 115:665-72. 2009
    ..The authors report on the local control and toxicity of stereotactic body radiotherapy (SBRT) for patients with unresectable pancreatic adenocarcinoma...
  30. ncbi request reprint Impact of integrated PET/CT on variability of target volume delineation in rectal cancer
    Deep A Patel
    Department of Radiation Oncology, Stanford University School of Medicine, 875 Blake Wibur Drive, Stanford, CA 94305 5847, USA
    Technol Cancer Res Treat 6:31-6. 2007
    ..The use of FDG and FLT did not appear to be different from this perspective...
  31. doi request reprint PET/CT imaging of gastrointestinal stromal tumor with calcified peritoneal implants after imatinib therapy
    Hedieh K Eslamy
    Department of Radiology, Division of Nuclear Medicine, Stanford University Medical Center, Stanford, California, USA
    Clin Nucl Med 33:864-5. 2008
    ..Serial PET/CT images demonstrated increasing calcification in peritoneal implants on CT and increasing FDG activity...
  32. ncbi request reprint Molecular imaging techniques in body imaging
    Daniel J A Margolis
    Department of Radiology, Stanford University School of Medicine, Stanford, CA, USA
    Radiology 245:333-56. 2007
    ..SPIO particles have also been used in the evaluation of the cirrhotic liver and at MR lymphangiography...
  33. doi request reprint Gemcitabine chemotherapy and single-fraction stereotactic body radiotherapy for locally advanced pancreatic cancer
    Devin Schellenberg
    Department of Radiation Oncology, Stanford University School of Medicine, Stanford, CA, USA
    Int J Radiat Oncol Biol Phys 72:678-86. 2008
    ..This prospective trial evaluated the efficacy of a single fraction of 25 Gy stereotactic body radiotherapy (SBRT) delivered between Cycle 1 and 2 of gemcitabine chemotherapy...
  34. ncbi request reprint Performance of 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography and integrated PET/CT in restaged breast cancer patients
    Barbara J Fueger
    Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Center, UCLA David Geffen School of Medicine, Los Angeles, CA 90095 6942, USA
    Mol Imaging Biol 7:369-76. 2005
    ..This study was conducted to compare the clinical stage derived from 2-deoxy-2-[F-18]fluoro-D-glucose (FDG) positron emission tomography (PET) to that of integrated PET/computed tomography (CT) in restaged breast cancer patients...
  35. ncbi request reprint Comparison between 2-deoxy-2-[18F]fluoro-D-glucose positron emission tomography and positron emission tomography/computed tomography hardware fusion for staging of patients with lymphoma
    Martin Allen-Auerbach
    Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Center, UCLA David Geffen School of Medicine at UCLA, Los Angeles, CA 90095 6942 USA
    Mol Imaging Biol 6:411-6. 2004
    ..We sought to determine whether integrated (hardware) fused PET/CT imaging results in further improvements in staging accuracy...
  36. ncbi request reprint Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability
    Benjamin S Halpern
    Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Center, David Geffen School of Medicine at UCLA, Los Angeles, California 90095 6942, USA
    J Nucl Med 45:797-801. 2004
    ..This study was performed to prospectively evaluate fast PET/CT imaging protocols using lutetium oxyorthosilicate (LSO) detector technology and 3-dimensional (3D) image-acquisition protocols...
  37. ncbi request reprint Conventional imaging and 2-deoxy-2-[(18)F]fluoro-D-glucose positron emission tomography for predicting the clinical outcome of patients with previously treated Hodgkin's disease
    Jean Emmanuel Filmont
    Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Clinic, UCLA School of Medicine, Los Angeles, CA, USA
    Mol Imaging Biol 6:47-54. 2004
    ..The aim of this study was to determine the ability of 2-deoxy-2-[(18)F]fluoro-d-glucose positron emission tomography (FDG-PET) to predict the clinical outcome of previously treated patients with Hodgkin's Disease (HD)...
  38. ncbi request reprint Relationship between 18F-FDG uptake and breast density in women with normal breast tissue
    Duska Vranjesevic
    Department of Molecular and Medical Pharmacology, Ahmanson Biological Imaging Clinic Nuclear Medicine, UCLA School of Medicine, 10833 Le Conte Avenue, Los Angeles, CA 90095 6942, USA
    J Nucl Med 44:1238-42. 2003
    ..Breast density affects the mammographic detectability of breast cancer. The study aimed to evaluate the impact of breast density on the (18)F-FDG uptake of normal breast tissue...
  39. ncbi request reprint Value of F-18 fluorodeoxyglucose positron emission tomography for predicting the clinical outcome of patients with aggressive lymphoma prior to and after autologous stem-cell transplantation
    Jean Emmanuel Filmont
    Ahmanson Biological Imaging Clinic, Department of Molecular and Medical Pharmacology, UCLA School of Medicine, Los Angeles, CA 90095, USA
    Chest 124:608-13. 2003
    ....